Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Glycine - Moligand™, ≥99% , CAS No.56-40-6
Zu bestellen verfügbar
Navigation umschalten 
Suche
340,000+ Forschungsprodukte · Triple ISO certified · COA & SDS für jedes Produkt verfügbar · Versand am selben Tag für Lagerartikel
Warum diese Qualität
Moligand™, ≥99% Moligand™ für empfindliche chromatographische und analytische Workflows, die minimale Basislinieninterferenzen erfordern.
Lagerung & Versand
Argon charged,Room temperature Versand Normal. Genaue Spezifikationen finden Sie im chargenspezifischen COA.
Qualitätsdokumente
SDS, COA, Datenblatt und Spezifikationsblatt stehen zum Download bereit. Chargenspezifische COA über Chargennummernsuche abrufbar.
Literaturbeleg
In 1156 peer-reviewten Publikationen zu Chromatographie, organischer Synthese und Kreuzkupplungsreaktionen zitiert.
Übersicht
Glycine is widely used as a buffer for a variety of immunological applications. It is frequently used in the preparation of TG Buffers (Tris-Glycine) where the buffer is used as a running and/or transfer buffer for polyacrylamide gel electrophoresis and western blotting. Glycine (100 mM, pH 2.0-2.5) is also used as an eluent in column chromatography. Glycine has been reported for use in the enzymatic determination of lactate using lactic dehydrogenase.
Glycine is a component of Tris-glycine and Tris-glycine-SDS running buffers for polyacrylamide gel electrophoresis. Glycine is also a component of Towbin′s transfer buffer for Western blots
Spezifikationen
Synonyme
Glycocoll | aminoacetic acid | H-Gly-OH
Spezifikationen & Reinheit
Moligand™, ≥99%
Biochemische und physiologische Mechanismen
Glycine is a non essential amino acid. Calcium influx through the cell membrane is mediated by glycine gated channels. Glycine participates in the synthesis of porphyrins, purines, and serines. It can also serve as a competitive agonist for binding glutam
Storage
Argon charged,Room temperature
Verschickt in
Normal
Note
Moligand™
Hinweis
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Reinheit
≥99%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488179545
Kanonisches Lächeln
C(C(=O)O)N
IUPAC Name
2-aminoacetic acid
InChIKey
DHMQDGOQFOQNFH-UHFFFAOYSA-N
INCHI
1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
Isomere SMILES
C(C(=O)O)N
WGK Deutschland
1
RTECS
MB7600000
Molekulargewicht
75.07
Beilstein
635782
Reaxy-Rn
635782
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=635782&ln=
Dokumentation
📋 Sicherheitsdatenblatt (SDS)
Umfassendes Dokument zu Gefahren, Handhabung, Lagerung und Einhaltung regulatorischer Vorschriften.
<<<<<<< HEAD SDS herunterladen → ======= SDS herunterladen → >>>>>>> release248-p3✅ Analysezertifikat (COA)
Chargenspezifische Qualitätsdaten. Geben Sie Ihre Chargennummer ein, um das genaue COA abzurufen.
COA nachschlagen →🔬 Spezifikationsblatt
Vollständige Qualitätsmerkmale und Akzeptanzkriterien für diese Qualität.
Spezifikationsblatt ansehen →Erweiterte Daten
Taxonomic Classification
Taxonomy Tree
- Kingdom Organic compounds
- Superclass Organic acids and derivatives
- Klasse Carboxylic acids and derivatives
- Subclass Amino acids, peptides, and analogues
- Ebene5 Amino acids and derivatives
- Ebene6 Alpha amino acids and derivatives
- Ebene7 Alpha amino acids
- Ebene6 Alpha amino acids and derivatives
- Ebene5 Amino acids and derivatives
- Subclass Amino acids, peptides, and analogues
- Klasse Carboxylic acids and derivatives
- Superclass Organic acids and derivatives
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Klasse | Carboxylic acids and derivatives |
| Subclass | Amino acids, peptides, and analogues |
| Intermediate Tree Nodes | Amino acids and derivatives - Alpha amino acids and derivatives |
| Direct Parent | Alpha amino acids |
| Alternative Parents | Amino acids Monocarboxylic acids and derivatives Carboxylic acids Organopnictogen compounds Organic oxides Monoalkylamines Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | Alpha-amino acid - Amino acid - Carboxylic acid - Monocarboxylic acid or derivatives - Organic nitrogen compound - Organic oxide - Hydrocarbon derivative - Primary amine - Organooxygen compound - Organonitrogen compound - Organopnictogen compound - Primary aliphatic amine - Organic oxygen compound - Carbonyl group - Amine - Aliphatic acyclic compound |
| Beschreibung | This compound belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). |
| External Descriptors | Common amino acids - Amino acids |
3D-Struktur
Interaktives chemisches Strukturmodell
Zugehörige Ziele (menschlich)
GPRC6A Tchem G-protein coupled receptor family C group 6 member A (1 Activities)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
F2 Tclin Thrombin (11687 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CA2 Tclin Carbonic anhydrase II (17698 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HMGCR Tclin HMG-CoA reductase (2475 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
INSR Tclin Insulin receptor (5558 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PGR Tclin Progesterone receptor (8562 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AR Tclin Androgen Receptor (11781 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MAOA Tclin Monoamine oxidase A (11911 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACHE Tclin Acetylcholinesterase (18204 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HRH2 Tclin Histamine H2 receptor (5428 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A1 Tclin GABA transporter 1 (308 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CALCR Tclin Calcitonin receptor (2215 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A4 Tclin Serotonin transporter (12625 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HRH1 Tclin Histamine H1 receptor (7573 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRM1 Tclin Mu opioid receptor (19785 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRD1 Tclin Delta opioid receptor (15096 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A3 Tclin Dopamine transporter (10535 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
KCNH2 Tclin HERG (29587 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Zugehörige Ziele (nicht menschlich)
Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mc4r Melanocortin receptor 4 (1205 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Ltc4s Leukotriene C4 synthase (1 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Sigmar1 Sigma opioid receptor (160 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cckar Cholecystokinin A receptor (90 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Nos2 Nitric oxide synthase, inducible (3573 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mapk1 MAP kinase ERK2 (650 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Slc6a9 Glycine transporter 1 (255 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Hdac6 Histone deacetylase 6 (222 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mmp9 Matrix metalloproteinase 9 (38 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Glra1 Glycine receptor subunit alpha-1 (65 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mus musculus (284745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Rattus norvegicus (775804 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Slc6a11 GABA transporter 4 (930 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
rep Replicase polyprotein 1ab (378 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Chrna3 Neuronal acetylcholine receptor; alpha3/beta4 (1368 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Grin1 Glutamate NMDA receptor (6467 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Slc16a10 Monocarboxylate transporter 10 (73 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Grin1 Glutamate NMDA receptor; Grin1/Grin2b (1028 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Grin1 Glutamate NMDA receptor; Grin1/Grin2a (798 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Grin1 Glutamate NMDA receptor; Grin1/Grin2c (1127 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Glra2 Glycine receptor (1745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Slc1a5 Amino acid transporter (271 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SARS-CoV-2 (38078 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Datum | Artikel |
|---|---|---|---|
 I2623557 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| J2619134 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| J2619135 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| J2619136 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| J2619137 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| J2619138 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| J2619139 | Certificate of Analysis | Sep 21, 2026 | A110749 |
| I2616192 | Certificate of Analysis | Sep 08, 2026 | A110749 |
| I2616193 | Certificate of Analysis | Sep 08, 2026 | A110749 |
| I2616194 | Certificate of Analysis | Sep 08, 2026 | A110749 |
| I2616195 | Certificate of Analysis | Sep 08, 2026 | A110749 |
| I2616196 | Certificate of Analysis | Sep 08, 2026 | A110749 |
| I2616197 | Certificate of Analysis | Sep 08, 2026 | A110749 |
| F2605419 | Certificate of Analysis | May 26, 2026 | A110749 |
| F2605420 | Certificate of Analysis | May 26, 2026 | A110749 |
| F2605421 | Certificate of Analysis | May 26, 2026 | A110749 |
| F2605422 | Certificate of Analysis | May 26, 2026 | A110749 |
| F2605424 | Certificate of Analysis | May 26, 2026 | A110749 |
| F2605425 | Certificate of Analysis | May 26, 2026 | A110749 |
| C2631177 | Certificate of Analysis | Apr 15, 2026 | A110749 |
| C2631178 | Certificate of Analysis | Apr 15, 2026 | A110749 |
| C2631179 | Certificate of Analysis | Apr 15, 2026 | A110749 |
| C2631183 | Certificate of Analysis | Apr 15, 2026 | A110749 |
| C2631186 | Certificate of Analysis | Apr 15, 2026 | A110749 |
| C2631187 | Certificate of Analysis | Apr 15, 2026 | A110749 |
| C2612244 | Certificate of Analysis | Mar 05, 2026 | A110749 |
| C2612245 | Certificate of Analysis | Mar 05, 2026 | A110749 |
| C2612246 | Certificate of Analysis | Mar 05, 2026 | A110749 |
| C2612247 | Certificate of Analysis | Mar 05, 2026 | A110749 |
| C2612248 | Certificate of Analysis | Mar 05, 2026 | A110749 |
| A2630026 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| I2505165 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| I2505166 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| I2505182 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| I2505229 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| I2505230 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| I2505242 | Certificate of Analysis | Aug 28, 2025 | A110749 |
| G2514116 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| G2514121 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| G2514122 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| G2514123 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| G2514124 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| H2507225 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| H2507226 | Certificate of Analysis | Jul 05, 2025 | A110749 |
| E2513132 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| E2513142 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| E2513151 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| E2513177 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| E2513185 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| F2504200 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| F2504211 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| F2504212 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| F2504245 | Certificate of Analysis | Apr 28, 2025 | A110749 |
| A2513171 | Certificate of Analysis | Dec 25, 2024 | A110749 |
| A2513172 | Certificate of Analysis | Dec 25, 2024 | A110749 |
| A2513173 | Certificate of Analysis | Dec 25, 2024 | A110749 |
| A2513177 | Certificate of Analysis | Dec 25, 2024 | A110749 |
| A2513179 | Certificate of Analysis | Dec 25, 2024 | A110749 |
| A2513506 | Certificate of Analysis | Dec 25, 2024 | A110749 |
| K2426286 | Certificate of Analysis | Nov 18, 2024 | A110749 |
| K2426287 | Certificate of Analysis | Nov 18, 2024 | A110749 |
| K2426288 | Certificate of Analysis | Nov 18, 2024 | A110749 |
| K2426289 | Certificate of Analysis | Nov 18, 2024 | A110749 |
| K2426290 | Certificate of Analysis | Nov 18, 2024 | A110749 |
| K2426291 | Certificate of Analysis | Nov 18, 2024 | A110749 |
| H2420245 | Certificate of Analysis | Aug 08, 2024 | A110749 |
| H2420246 | Certificate of Analysis | Aug 08, 2024 | A110749 |
| H2420255 | Certificate of Analysis | Aug 08, 2024 | A110749 |
| H2420256 | Certificate of Analysis | Aug 08, 2024 | A110749 |
| H2420260 | Certificate of Analysis | Aug 08, 2024 | A110749 |
| H2420261 | Certificate of Analysis | Aug 08, 2024 | A110749 |
| J2424353 | Certificate of Analysis | Jul 01, 2024 | A110749 |
| J2424354 | Certificate of Analysis | Jul 01, 2024 | A110749 |
| K2404116 | Certificate of Analysis | Jun 28, 2024 | A110749 |
| K2404117 | Certificate of Analysis | Jun 28, 2024 | A110749 |
| B2627338 | Certificate of Analysis | Jun 28, 2024 | A110749 |
| F2429056 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| F2429057 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| F2429066 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| F2429069 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| F2429076 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| F2429168 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| J2428230 | Certificate of Analysis | Jun 06, 2024 | A110749 |
| C2407201 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| C2407203 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| C2407204 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| C2407205 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| C2407211 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| C2407327 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| C2407329 | Certificate of Analysis | Feb 26, 2024 | A110749 |
| A2408045 | Certificate of Analysis | Jan 11, 2024 | A110749 |
| A2408047 | Certificate of Analysis | Jan 11, 2024 | A110749 |
| A2408055 | Certificate of Analysis | Jan 11, 2024 | A110749 |
| A2408049 | Certificate of Analysis | Jan 10, 2024 | A110749 |
| A2408050 | Certificate of Analysis | Jan 10, 2024 | A110749 |
| A2408052 | Certificate of Analysis | Jan 10, 2024 | A110749 |
| A2408054 | Certificate of Analysis | Jan 10, 2024 | A110749 |
| A2408058 | Certificate of Analysis | Jan 10, 2024 | A110749 |
| J2327015 | Certificate of Analysis | Nov 07, 2023 | A110749 |
| J2327016 | Certificate of Analysis | Nov 07, 2023 | A110749 |
| J2327017 | Certificate of Analysis | Nov 07, 2023 | A110749 |
| J2327018 | Certificate of Analysis | Nov 07, 2023 | A110749 |
| H2308229 | Certificate of Analysis | Aug 14, 2023 | A110749 |
| G2307518 | Certificate of Analysis | Jul 15, 2023 | A110749 |
| D2321538 | Certificate of Analysis | Apr 24, 2023 | A110749 |
| D2321540 | Certificate of Analysis | Apr 24, 2023 | A110749 |
| D2321541 | Certificate of Analysis | Apr 24, 2023 | A110749 |
| D2321536 | Certificate of Analysis | Apr 23, 2023 | A110749 |
| D2321537 | Certificate of Analysis | Apr 23, 2023 | A110749 |
| D2321539 | Certificate of Analysis | Apr 23, 2023 | A110749 |
| D2410025 | Certificate of Analysis | Apr 23, 2023 | A110749 |
| C2303398 | Certificate of Analysis | Mar 13, 2023 | A110749 |
| C2303399 | Certificate of Analysis | Mar 13, 2023 | A110749 |
| C2303403 | Certificate of Analysis | Mar 13, 2023 | A110749 |
| C2303404 | Certificate of Analysis | Mar 13, 2023 | A110749 |
| H2325008 | Certificate of Analysis | Mar 13, 2023 | A110749 |
| B2325278 | Certificate of Analysis | Mar 03, 2023 | A110749 |
| K2210257 | Certificate of Analysis | Nov 11, 2022 | A110749 |
| I2214043 | Certificate of Analysis | Sep 21, 2022 | A110749 |
| I2214047 | Certificate of Analysis | Sep 21, 2022 | A110749 |
| E2311048 | Certificate of Analysis | Sep 19, 2022 | A110749 |
| I2214041 | Certificate of Analysis | Sep 19, 2022 | A110749 |
| I2214042 | Certificate of Analysis | Sep 19, 2022 | A110749 |
| E2224002 | Certificate of Analysis | May 26, 2022 | A110749 |
| E2224003 | Certificate of Analysis | May 26, 2022 | A110749 |
| E2224004 | Certificate of Analysis | May 26, 2022 | A110749 |
| E2224005 | Certificate of Analysis | May 26, 2022 | A110749 |
| E2224010 | Certificate of Analysis | May 26, 2022 | A110749 |
| E2224217 | Certificate of Analysis | May 26, 2022 | A110749 |
| E2210005 | Certificate of Analysis | May 12, 2022 | A110749 |
| E2210006 | Certificate of Analysis | May 12, 2022 | A110749 |
| E2210007 | Certificate of Analysis | May 12, 2022 | A110749 |
| E2210008 | Certificate of Analysis | May 12, 2022 | A110749 |
| D2226045 | Certificate of Analysis | May 06, 2022 | A110749 |
| D2226056 | Certificate of Analysis | May 06, 2022 | A110749 |
| D2226067 | Certificate of Analysis | May 06, 2022 | A110749 |
| B2207202 | Certificate of Analysis | Feb 11, 2022 | A110749 |
| B2207200 | Certificate of Analysis | Feb 11, 2022 | A110749 |
| B2207201 | Certificate of Analysis | Feb 11, 2022 | A110749 |
| B2207203 | Certificate of Analysis | Feb 10, 2022 | A110749 |
| B2207204 | Certificate of Analysis | Feb 10, 2022 | A110749 |
| B2207214 | Certificate of Analysis | Feb 10, 2022 | A110749 |
| I2214045 | Certificate of Analysis | Feb 10, 2022 | A110749 |
| I2214046 | Certificate of Analysis | Feb 10, 2022 | A110749 |
Chemische und physikalische Eigenschaften
| Löslichkeit | Soluble in water (100 mg/ml), and acetone (slightly soluble). Insoluble in alcohol, and ether |
|---|---|
| Schmelzpunkt (°C) | 240 °C |
| Molekulargewicht | 75.070 g/mol |
| XLogP3 | -3.200 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 75.032 Da |
| Monoisotopic Mass | 75.032 Da |
| Topological Polar Surface Area | 63.300 Ų |
| Heavy Atom Count | 5 |
| Formal Charge | 0 |
| Complexity | 42.900 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
FAQs und Artikel
Standard Operating Procedure (SOP) for the Protein Tris–Glycine Electrophoresis System
Categories: Laboratory Protocols & SOPs Library
Citations of This Product
Lösungsrechner
Bewertungen
Kundenbewertungen
Benötigen Sie Hilfe bei der Auswahl der Qualität?
Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.
Moligand™ Qualitätsleitfaden ansehen →Verwandte Produkte
Glycine - Moligand™, ACS, ≥98.5% , CAS No.56-40-6
Glycine - Moligand™, for electrophoresis, ≥99% , CAS No.56-40-6
Aminoacetic acid - Moligand™, Suitable for molecular biology, ≥99%(NT) , CAS No.56-40-6
Glycine - PharmPure™,USP,BP,Ph.Eur.,≥99% , sodium-coupled neutral amino acid transporter 4;Agonist of GluN1;Agonist of GluN2A;Agonist of GluN2B;Agonist of GluN2C;Agonist of GluN2D;Agonist of GPRC6 receptor, CAS No.56-40-6
Glycine - Moligand™, 0.3M in water(pH3.0±0.2) , CAS No.56-40-6
Aminoacetic acid - Moligand™, 10mM in Water , CAS No.56-40-6
Aminoacetic acid - Moligand™, analytical standard , Agonist of GluN1;Agonist of GluN2A;Agonist of GluN2B;Agonist of GluN2C;Agonist of GluN2D;Agonist of GPRC6 receptor, CAS No.56-40-6
Glycine - UltraBio™, Suitable for molecular biology, Ultra pure, ≥99%(NT) , CAS No.56-40-6
Glycine - UltraBio™, Ultra pure, ≥99%(T) , CAS No.56-40-6
Glycine - Moligand™, for synthesis , CAS No.56-40-6
Später erinnern
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
Copyright © 2023–present Aladdin Scientific Corporation. All rights reserved.